- New Pill Lowers Stubborn Blood Pressure and May Slow Kidney Disease SciTechDaily
- Baxdrostat Lowers Treatment-Resistant High BP in Patients With CKD Physician’s Weekly
- AstraZeneca’s Baxdrostat Study: A Potential Game-Changer for Resistant Hypertension TipRanks
- Baxdrostat significantly reduces hard-to-control hypertension, study finds Hospital Healthcare Europe
- New pill lowers hard-to-treat blood pressure and may protect kidneys Arab Times Kuwait News
Source link
